Quality outcomes for end-of-life care among people with haematological malignancies at a New Zealand cancer centre.

Background: Little is known about the end-of-life (EOL) experience and specialist palliative care use patterns of patients with haematological malignancies (HMs) in New Zealand.

Aims: This retrospective analysis sought to examine the quality of EOL care received by people with HMs under the care of Auckland District Health Board Cancer Centre's haematology service and compare it to international data where available.

Methods: One hundred consecutive adult patients with HMs who died on or before 31 December 2019 were identified.